New Zealand markets open in 6 hours 15 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
296.82-3.45 (-1.15%)
At close: 04:00PM EDT
296.82 0.00 (0.00%)
After hours: 04:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.45B
Enterprise value 8.21B
Trailing P/E N/A
Forward P/E 27.25
PEG ratio (5-yr expected) 1.19
Price/sales (ttm)3.30
Price/book (mrq)0.94
Enterprise value/revenue 3.15
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-28.80%
S&P500 52-week change 320.87%
52-week high 3431.79
52-week low 3261.59
50-day moving average 3286.97
200-day moving average 3307.16

Share statistics

Avg vol (3-month) 3256.08k
Avg vol (10-day) 3251.13k
Shares outstanding 523.45M
Implied shares outstanding 628.58M
Float 819.97M
% held by insiders 115.20%
% held by institutions 182.58%
Shares short (28 Jun 2024) 41.28M
Short ratio (28 Jun 2024) 44.2
Short % of float (28 Jun 2024) 47.19%
Short % of shares outstanding (28 Jun 2024) 44.50%
Shares short (prior month 31 May 2024) 4752.15k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 308 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -12.37%
Operating margin (ttm)8.48%

Management effectiveness

Return on assets (ttm)1.69%
Return on equity (ttm)-3.43%

Income statement

Revenue (ttm)2.61B
Revenue per share (ttm)90.02
Quarterly revenue growth (yoy)-9.80%
Gross profit (ttm)N/A
EBITDA 502.99M
Net income avi to common (ttm)-322.37M
Diluted EPS (ttm)-10.69
Quarterly earnings growth (yoy)456.70%

Balance sheet

Total cash (mrq)1.65B
Total cash per share (mrq)57.69
Total debt (mrq)1.4B
Total debt/equity (mrq)15.47%
Current ratio (mrq)6.57
Book value per share (mrq)317.32

Cash flow statement

Operating cash flow (ttm)346.57M
Levered free cash flow (ttm)120.82M